Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Gerhard Hamilton & Adelina Plangger. (2021) The Impact of NK Cell-Based Therapeutics for the Treatment of Lung Cancer for Biologics: Targets and Therapy. Biologics: Targets and Therapy 15, pages 265-277.
Read now
Read now
A. Graham Pockley, Peter Vaupel & Gabriele Multhoff. (2020) NK cell-based therapeutics for lung cancer. Expert Opinion on Biological Therapy 20:1, pages 23-33.
Read now
Read now
Hajar Rajayi, Parsova Tavasolian, Alaleh Rezalotfi & Marzieh Ebrahimi. (2019) Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche. International Reviews of Immunology 38:6, pages 267-283.
Read now
Read now
Kristina Ellwanger, Uwe Reusch, Ivica Fucek, Susanne Wingert, Thorsten Ross, Thomas Müller, Ute Schniegler-Mattox, Torsten Haneke, Erich Rajkovic, Joachim Koch, Martin Treder & Michael Tesar. (2019) Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunity. mAbs 11:5, pages 899-918.
Read now
Read now
Liang Wang, Tianmin Xu & Manhua Cui. (2018) Are ovarian cancer stem cells the target for innovative immunotherapy?. OncoTargets and Therapy 11, pages 2615-2626.
Read now
Read now
Articles from other publishers (65)
Diego Esperante, Mónica Itzel Martínez Gutiérrez, Mark E. Issa, Alejandro Schcolnik-Cabrera & Fela Mendlovic. (2023) Similarities and divergences in the metabolism of immune cells in cancer and helminthic infections. Frontiers in Oncology 13.
Crossref
Crossref
Leisheng Zhang & Hui Cai. 2023. Cytotoxicity - Understanding Cellular Damage and Response. Cytotoxicity - Understanding Cellular Damage and Response.
Jason Chiang, Po-Chun Chen, Janet Pham, Cat-Quynh Nguyen, Kawaljit Kaur, Steven S. Raman & Anahid Jewett. (2023) Characterizing hepatocellular carcinoma stem markers and their corresponding susceptibility to NK-cell based immunotherapy. Frontiers in Immunology 14.
Crossref
Crossref
Mia C. Borlongan, Dipongkor Saha & Hongbin Wang. (2023) Tumor Microenvironment: A Niche for Cancer Stem Cell Immunotherapy. Stem Cell Reviews and Reports.
Crossref
Crossref
Amirhossein Izadpanah, Niloufar Mohammadkhani, Mina Masoudnia, Mahsa Ghasemzad, Arefeh Saeedian, Hamid Mehdizadeh, Mansour Poorebrahim & Marzieh Ebrahimi. (2023) Update on immune‐based therapy strategies targeting cancer stem cells. Cancer Medicine.
Crossref
Crossref
Feifei Guo, Yi Zhang, Ling Bai & Jiuwei Cui. (2023) Natural killer cell therapy targeting cancer stem cells: Old wine in a new bottle. Cancer Letters 570, pages 216328.
Crossref
Crossref
Wei Ye, Meiye Li & Kewang Luo. (2023) Therapies Targeting Immune Cells in Tumor Microenvironment for Non-Small Cell Lung Cancer. Pharmaceutics 15:7, pages 1788.
Crossref
Crossref
Sara Razi, Amin Haghparast, Sepide Chodari Khameneh, Amin Ebrahimi Sadrabadi, Fatemeh Aziziyan, Maryam Bakhtiyari, Mohsen Nabi-Afjadi, Vahideh Tarhriz, Arsalan Jalili & Hamidreza Zalpoor. (2023) The role of tumor microenvironment on cancer stem cell fate in solid tumors. Cell Communication and Signaling 21:1.
Crossref
Crossref
S. Pan, F. Wang, J. Jiang, Z. Lin, Z. Chen, T. Cao & L. Yang. (2023) Chimeric Antigen Receptor-Natural Killer Cells: A New Breakthrough in the Treatment of Solid Tumours. Clinical Oncology 35:3, pages 153-162.
Crossref
Crossref
Kawaljit Kaur & Anahid Jewett. (2023) Supercharged NK Cell-Based Immuotherapy in Humanized Bone Marrow Liver and Thymus (Hu-BLT) Mice Model of Oral, Pancreatic, Glioblastoma, Hepatic, Melanoma and Ovarian Cancers. Critical Reviews in Immunology 43:2, pages 13-25.
Crossref
Crossref
Thuy Mau Thi Nguyen, Khanh Van Tran, Van Thanh Ta, Linh Mai Tran, Chi Khanh Tran, Huy Le Trinh, Dat Thanh Ta, Binh Thanh Nguyen & Thinh Huy Tran. (2023) A case of response to combination treatment with autologous immunotherapy and bevacizumab in advanced non-small cell lung cancer. Respiratory Medicine Case Reports 42, pages 101804.
Crossref
Crossref
Ysabel Alessa Schwietzer, Katharina Helene Susek, Ziqing Chen, Evren Alici & Arnika Kathleen Wagner. 2023. The Immunological Synapse – Part B. The Immunological Synapse – Part B
43
61
.
Daria S. Chulpanova, Albert A. Rizvanov & Valeriya V. Solovyeva. (2022) The Role of Cancer Stem Cells and Their Extracellular Vesicles in the Modulation of the Antitumor Immunity. International Journal of Molecular Sciences 24:1, pages 395.
Crossref
Crossref
Marta Włodarczyk & Beata Pyrzynska. (2022) CAR-NK as a Rapidly Developed and Efficient Immunotherapeutic Strategy against Cancer. Cancers 15:1, pages 117.
Crossref
Crossref
Hoon Sik Choi, Young Shin Ko, Hana Jin, Ki Mun Kang, In Bong Ha, Hojin Jeong, Jeong-hee Lee, Bae Kwon Jeong & Hye Jung Kim. (2022) Mebendazole Increases Anticancer Activity of Radiotherapy in Radiotherapy-Resistant Triple-Negative Breast Cancer Cells by Enhancing Natural Killer Cell-Mediated Cytotoxicity. International Journal of Molecular Sciences 23:24, pages 15493.
Crossref
Crossref
Eyüp BAŞARAN, Reşit ÇAKMAK, Ercan ÇINAR & Ozge CEVİK. (2022) Some Heterocyclic Hydrazone Compounds: Synthesis, Spectral Characterization and Anticancer Activity Study. Cumhuriyet Science Journal 43:3, pages 437-442.
Crossref
Crossref
Laura Damele, Grazia Maria Spaggiari, Monica Parodi, Maria Cristina Mingari, Massimo Vitale & Chiara Vitale. (2022) Cord Blood-Derived Natural Killer Cell Exploitation in Immunotherapy Protocols: More Than a Promise?. Cancers 14:18, pages 4439.
Crossref
Crossref
Deeptha Ishwar, Rupa Haldavnekar, Krishnan Venkatakrishnan & Bo Tan. (2022) Minimally invasive detection of cancer using metabolic changes in tumor-associated natural killer cells with Oncoimmune probes. Nature Communications 13:1.
Crossref
Crossref
Yihang Gong, Wenjie Chen, Xiuxing Chen, Yizhan He, Hua Jiang, Xijian Zhang, Lijie Pan, Beibei Ni, Fan Yang, Yan Xu, Qi Zhang, Lei Zhou & Yusheng Cheng. (2022) An Injectable Epigenetic Autophagic Modulatory Hydrogel for Boosting Umbilical Cord Blood NK Cell Therapy Prevents Postsurgical Relapse of Triple‐Negative Breast Cancer. Advanced Science 9:23.
Crossref
Crossref
Alicia Cristina Peña-Romero & Esteban Orenes-Piñero. (2022) Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers. Cancers 14:7, pages 1681.
Crossref
Crossref
Yang Zhou, Jiang Xu, Haichang Luo, Xiangjing Meng, Ming Chen & Di Zhu. (2022) Wnt signaling pathway in cancer immunotherapy. Cancer Letters 525, pages 84-96.
Crossref
Crossref
Davide Cinat, Robert P. Coppes & Lara Barazzuol. (2021) DNA Damage-Induced Inflammatory Microenvironment and Adult Stem Cell Response. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Jin Cao, Shubhmita Bhatnagar, Jiawei Wang, Xueyong Qi, Swayam Prabha & Jayanth Panyam. (2020) Cancer stem cells and strategies for targeted drug delivery. Drug Delivery and Translational Research 11:5, pages 1779-1805.
Crossref
Crossref
Patrycja Czerwinska & Andrzej Adam Mackiewicz. (2021) Low Levels of TRIM28-Interacting KRAB-ZNF Genes Associate with Cancer Stemness and Predict Poor Prognosis of Kidney Renal Clear Cell Carcinoma Patients. Cancers 13:19, pages 4835.
Crossref
Crossref
Kamakshi Prudhula Devalraju, Venkata Sanjeev Kumar Neela, Siva Sai Krovvidi, Ramakrishna Vankayalapati & Vijaya Lakshmi Valluri. (2021) Defective expansion and function of memory like natural killer cells in HIV+ individuals with latent tuberculosis infection. PLOS ONE 16:9, pages e0257185.
Crossref
Crossref
Katherine Po Sin Chung, Rainbow Wing Hei Leung & Terence Kin Wah Lee. (2021) Hampering Stromal Cells in the Tumor Microenvironment as a Therapeutic Strategy to Destem Cancer Stem Cells. Cancers 13:13, pages 3191.
Crossref
Crossref
Paolo Sportoletti, Filomena De Falco, Beatrice Del Papa, Stefano Baldoni, Valerio Guarente, Andrea Marra, Erica Dorillo, Chiara Rompietti, Francesco Maria Adamo, Loredana Ruggeri, Mauro Di Ianni & Emanuela Rosati. (2021) NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications. International Journal of Molecular Sciences 22:13, pages 6665.
Crossref
Crossref
Esraa Elaraby, Abdullah Imadeddin Malek, Hanan W. Abdullah, Noha Mousaad Elemam, Maha Saber-Ayad & Iman M. Talaat. (2021) Natural Killer Cell Dysfunction in Obese Patients with Breast Cancer: A Review of a Triad and Its Implications. Journal of Immunology Research 2021, pages 1-10.
Crossref
Crossref
Ewa Wrona, Maciej Borowiec & Piotr Potemski. (2021) CAR-NK Cells in the Treatment of Solid Tumors. International Journal of Molecular Sciences 22:11, pages 5899.
Crossref
Crossref
Cristina Capuano, Chiara Pighi, Simone Battella, Davide De Federicis, Ricciarda Galandrini & Gabriella Palmieri. (2021) Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs. Cancers 13:10, pages 2500.
Crossref
Crossref
Srishti Jain, Stephanie L. Annett, Maria P. Morgan & Tracy Robson. (2021) The Cancer Stem Cell Niche in Ovarian Cancer and Its Impact on Immune Surveillance. International Journal of Molecular Sciences 22:8, pages 4091.
Crossref
Crossref
Soraia Fernandes, Tamara Fernandez, Sabrina Metze, Preethi B. Balakrishnan, Binh T. Mai, John Conteh, Claudia De Mei, Alice Turdo, Simone Di Franco, Giorgio Stassi, Matilde Todaro & Teresa Pellegrino. (2021) Magnetic Nanoparticle-Based Hyperthermia Mediates Drug Delivery and Impairs the Tumorigenic Capacity of Quiescent Colorectal Cancer Stem Cells. ACS Applied Materials & Interfaces 13:14, pages 15959-15972.
Crossref
Crossref
Chiara Donini, Ramona Rotolo, Alessia Proment, Massimo Aglietta, Dario Sangiolo & Valeria Leuci. (2021) Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective. Cells 10:3, pages 543.
Crossref
Crossref
Elisa C. Toffoli, Abdolkarim Sheikhi, Yannick D. Höppner, Pita de Kok, Mahsa Yazdanpanah-Samani, Jan Spanholtz, Henk M. W. Verheul, Hans J. van der Vliet & Tanja D. de Gruijl. (2021) Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic Response. Cancers 13:4, pages 711.
Crossref
Crossref
Chie Kudo-Saito, Yukinori Ozaki, Hiroshi Imazeki, Hideyuki Hayashi, Jun Masuda, Hiroki Ozawa & Yamato Ogiwara. (2021) Targeting Oncoimmune Drivers of Cancer Metastasis. Cancers 13:3, pages 554.
Crossref
Crossref
Dan Wu, Xin Shou, Yalan Zhang, Zihan Li, Guohua Wu, Di Wu, Jianguo Wu, Shengyu Shi & Shuqi Wang. (2021) Cell membrane-encapsulated magnetic nanoparticles for enhancing natural killer cell-mediated cancer immunotherapy. Nanomedicine: Nanotechnology, Biology and Medicine 32, pages 102333.
Crossref
Crossref
Lorenzo Mortara, Denisa Baci, Grace Coco, Alessandro Poggi & Antonino Bruno. 2021. Successes and Challenges of NK Immunotherapy. Successes and Challenges of NK Immunotherapy
305
347
.
Pengchao Fang, Liuting Zhou, Lee Y. Lim, Hualin Fu, Zhi-xiang Yuan & Juchun Lin. (2020) Targeting Strategies for Renal Cancer Stem Cell Therapy. Current Pharmaceutical Design 26:17, pages 1964-1978.
Crossref
Crossref
Qiang Liu, Jian Gu, E Zhang, Lili He & Zhi-xiang Yuan. (2020) Targeted Delivery of Therapeutics to Urological Cancer Stem Cells. Current Pharmaceutical Design 26:17, pages 2038-2056.
Crossref
Crossref
Justin K. Messex, Crystal J. Byrd & Geou-Yarh Liou. (2020) Signaling of Macrophages that Contours the Tumor Microenvironment for Promoting Cancer Development. Cells 9:4, pages 919.
Crossref
Crossref
Monish Ram Makena, Alok Ranjan, Vani Thirumala & Arubala P Reddy. (2020) Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1866:4, pages 165339.
Crossref
Crossref
Dong Jun Park, Pil Soo Sung, Jung-Hee Kim, Gil Won Lee, Jeong Won Jang, Eun Sun Jung, Si Hyun Bae, Jong Young Choi & Seung Kew Yoon. (2020) EpCAM-high liver cancer stem cells resist natural killer cell–mediated cytotoxicity by upregulating CEACAM1. Journal for ImmunoTherapy of Cancer 8:1, pages e000301.
Crossref
Crossref
Maryam Moghadasi, Mohammadreza Alivand, Masoumeh Fardi, Kobra Shojaei Moghadam & Saeed Solali. (2020) Emerging molecular functions of microRNA-124: Cancer pathology and therapeutic implications. Pathology - Research and Practice 216:3, pages 152827.
Crossref
Crossref
Sean J. Judge, William J. Murphy & Robert J. Canter. (2020) Characterizing the Dysfunctional NK Cell: Assessing the Clinical Relevance of Exhaustion, Anergy, and Senescence. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Crossref
Ombretta Melaiu, Valeria Lucarini, Loredana Cifaldi & Doriana Fruci. (2020) Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors. Frontiers in Immunology 10.
Crossref
Crossref
Yuan-yuan Jin, Wen-zhuo Yang, Sen Zou, Zheng-yang Sun, Chun-tao Wu & Zhao-yong Yang. (2020) Chemoradiotherapy combined with NK cell transfer in a patient with recurrent and metastatic nasopharyngeal carcinoma inducing long-term tumor control. Medicine 99:43, pages e22785.
Crossref
Crossref
Jyothi Priya Mandala, Srinivas Pittala & Gowru Srivani. 2020. Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers. Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers
51
81
.
Alicia A. Gingrich, Jaime F. Modiano & Robert J. Canter. (2019) Characterization and Potential Applications of Dog Natural Killer Cells in Cancer Immunotherapy. Journal of Clinical Medicine 8:11, pages 1802.
Crossref
Crossref
Sooyeon Oh, Joo-Ho Lee, KyuBum Kwack & Sang-Woon Choi. (2019) Natural Killer Cell Therapy: A New Treatment Paradigm for Solid Tumors. Cancers 11:10, pages 1534.
Crossref
Crossref
Khalil Choucair, Joseph R Duff, Christine S Cassidy, Mary T Albrethsen, Jesse D Kelso, Amanda Lenhard, Hannah Staats, Rayna Patel, F Charles Brunicardi, Lance Dworkin & John Nemunaitis. (2019) Natural killer cells: a review of biology, therapeutic potential and challenges in treatment of solid tumors. Future Oncology 15:26, pages 3053-3069.
Crossref
Crossref
Fatemeh Vahidian, Pascal H.G. Duijf, Elham Safarzadeh, Afshin Derakhshani, Amir Baghbanzadeh & Behzad Baradaran. (2019) Interactions between cancer stem cells, immune system and some environmental components: Friends or foes?. Immunology Letters 208, pages 19-29.
Crossref
Crossref
Jesus Luna, Steven Grossenbacher, Ian Sturgill, Erik Ames, Sean Judge, Lyes Bouzid, Morgan Darrow, William Murphy & Robert Canter. (2019) Bortezomib Augments Natural Killer Cell Targeting of Stem-Like Tumor Cells. Cancers 11:1, pages 85.
Crossref
Crossref
Hassan Dianat‐Moghadam, Mohsen Rokni, Faroogh Marofi, Yunes Panahi & Mehdi Yousefi. (2018) Natural killer cell–based immunotherapy: From transplantation toward targeting cancer stem cells. Journal of Cellular Physiology 234:1, pages 259-273.
Crossref
Crossref
Shaoping Liu, Min Xu, Chengliang Zhu, Qiu Zhao & Feng Zhou. (2018)
Taste receptor T1R1/T1R3 promotes the tumoricidal activity of hepatic CD49a
+
CD49b
−
natural killer cells
. European Journal of Immunology 48:12, pages 2031-2041.
Crossref
Crossref
Andrea Costantini, Nadia Viola, Antonella Berretta, Roberta Galeazzi, Giulia Matacchione, Jacopo Sabbatinelli, Gianluca Storci, Serena De Matteis, Luca Butini, Maria Rita Rippo, Antonio Domenico Procopio, Daniele Caraceni, Roberto Antonicelli, Fabiola Olivieri & Massimiliano Bonafè. (2018) Age-related M1/M2 phenotype changes in circulating monocytes from healthy/unhealthy individuals. Aging 10:6, pages 1268-1280.
Crossref
Crossref
Aline Brito de Lima, Luciana Maria Silva, Nikole Gontijo Gonçales, Maria Raquel Santos Carvalho, Agnaldo Lopes da Silva Filho & Letícia da Conceição Braga. (2018) Three-Dimensional Cellular Arrangement in Epithelial Ovarian Cancer Cell Lines TOV-21G and SKOV-3 is Associated with Apoptosis-Related miRNA Expression Modulation. Cancer Microenvironment 11:1, pages 85-92.
Crossref
Crossref
Ozge Nur Aktaş, Ayşe Bilge Öztürk, Baran Erman, Suat Erus, Serhan Tanju & Şükrü Dilege. (2018) Role of natural killer cells in lung cancer. Journal of Cancer Research and Clinical Oncology 144:6, pages 997-1003.
Crossref
Crossref
May Daher & Katayoun Rezvani. (2018) Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering. Current Opinion in Immunology 51, pages 146-153.
Crossref
Crossref
Timothy Henderson, Mingyi Chen, Morgan A. Darrow, Chin-Shang Li, Chi-Lu Chiu, Arta M. Monjazeb, William J. Murphy & Robert J. Canter. (2018) Alterations in cancer stem-cell marker CD44 expression predict oncologic outcome in soft-tissue sarcomas. Journal of Surgical Research 223, pages 207-214.
Crossref
Crossref
Huang Zhu, Yi‐Shin Lai, Ye Li, Robert H. Blum & Dan S. Kaufman. (2018) Concise Review: Human Pluripotent Stem Cells to Produce Cell‐Based Cancer Immunotherapy. STEM CELLS 36:2, pages 134-145.
Crossref
Crossref
Lacy E. Lowry & William A. Zehring. (2017) Potentiation of Natural Killer Cells for Cancer Immunotherapy: A Review of Literature. Frontiers in Immunology 8.
Crossref
Crossref
Sunny Kumar, Siddharth S. Kesharwani, Bhimanna Kuppast, Mohammed Ali Bakkari & Hemachand Tummala. (2017) Pathogen-mimicking vaccine delivery system designed with a bioactive polymer (inulin acetate) for robust humoral and cellular immune responses. Journal of Controlled Release 261, pages 263-274.
Crossref
Crossref
Dimakatso Alice Senthebane, Arielle Rowe, Nicholas Ekow Thomford, Hendrina Shipanga, Daniella Munro, Mohammad A. M. Al Mazeedi, Hashim A. M. Almazyadi, Karlien Kallmeyer, Collet Dandara, Michael S. Pepper, M. Iqbal Parker & Kevin Dzobo. (2017) The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer. International Journal of Molecular Sciences 18:7, pages 1586.
Crossref
Crossref
Karl-Johan Malmberg, Mattias Carlsten, Andreas Björklund, Ebba Sohlberg, Yenan T. Bryceson & Hans-Gustaf Ljunggren. (2017) Natural killer cell-mediated immunosurveillance of human cancer. Seminars in Immunology 31, pages 20-29.
Crossref
Crossref
John P. Veluchamy, Nina Kok, Hans J. van der Vliet, Henk M. W. Verheul, Tanja D. de Gruijl & Jan Spanholtz. (2017) The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments. Frontiers in Immunology 8.
Crossref
Crossref